Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | MMP1 | P03956 | 1/20 | 0.30 |
| ▸ | MMP2 | P08253 | 1/20 | 0.30 |
| ▸ | MMP3 | P08254 | 1/20 | 0.30 |
| ▸ | MMP8 | P22894 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fluoride Ion SCHEMBL4607229 | 0.85 | EHMT2 (0.33) | TSHRALDH1A1LMNA | |
| Bromide SCHEMBL262065 | 0.85 | EHMT2 (0.33) | TSHRALDH1A1LMNA | |
| Hydrochloric Acid SCHEMBL261161 | 0.85 | EHMT2 (0.33) | TSHRALDH1A1LMNA | |
| Nitrous Acid SCHEMBL7032189 | 0.84 | LMNA (0.30) | LMNA | |
| Acetic Acid SCHEMBL261148 | 0.84 | CA1 (0.36) | LMNAMMP1MMP2MMP3MMP8 | |
| Sulfuric Acid SCHEMBL7028500 | 0.82 | MEN1 (0.33) | TSHRALDH1A1 | |
| SCHEMBL262265 | 0.82 | — | — | |
| SCHEMBL7033765 | 0.78 | TSHR (0.35) | TSHRALDH1A1LMNAMMP1MMP2 | |
| SCHEMBL7032131 | 0.78 | — | — | |
| SCHEMBL8717245 | 0.76 | CA12 (0.37) | TSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030163000-A1 | Halogen exchange reactions and catalysts therefor | CHORDIP LTD. (GB) | 2003-08-28 | — | — | US | disclosed |
| EP-1288196-A1 | Process for the preparation of organo guanidinium salts | Chordip Ltd. (GB) | 2003-03-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030163000-A1 | Halogen exchange reactions and catalysts therefor | WEE2, WEE1, SLC39A11 | TSHR 2156/4885ALDH1A1 3237/4885LMNA 4671/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.